This ASX 200 healthcare share has a fully franked dividend yield over 4% right now

This ASX 200 healthcare share offers a dividend yield over 4% right now…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The ASX 200 is home to many dividend-paying shares
  • But not too many healthcare shares offer high dividend yields today
  • But let's look at one that is boasting a 4% yield right now...

Sure there are a lot of ASX dividend shares on the S&P/ASX 200 Index (ASX: XJO) to choose from. There are the big banks like Commonwealth Bank of Australia (ASX: CBA). Then there are the mining giants like BHP Group Ltd (ASX: BHP). Other dividend investors look to blue-chips like Telstra Corporation Ltd (ASX: TLS), or Wesfarmers Ltd (ASX: WES) for income. But dividend-paying ASX healthcare shares?

Traditionally, the healthcare space is not one where many investors traditionally search for income. The market's largest healthcare share is CSL Limited (ASX: CSL). But even though CSL shares have fallen more than 8% this year so far, the company still has a dividend yield under 1%.

But there is a healthcare share on the ASX that currently offers a fully franked dividend yield of over 4% right now. That would be Medibank Private Ltd (ASX: MPL).

Medibank Private is the ASX's largest healthcare insurer. Many of us would know its flagship Medibank brand, as well as its AHM subsidiary.

Well, right now, Medibank Private shares offer a dividend yield of 4.06%. Since this yield comes fully franked too, it grosses up to a meaty 5.8% with those franking credits. 

Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

How do Medibank shares offer a 4% yield today?

Where does this yield come from? Well, Medibank's last two dividend payments. The company paid out its interim dividend for FY2022 last month This was a payment of 6.2 cents per share, a healthy rise on the previous interim dividend of 5.8 cents per share. Before that, Medibank doled out a final dividend of 6.9 cents per share in September last year. Again, that was an increase on its 2020 final payment of 6.3 cents per share.

Medibank actually had a bit of a streak going before COVID. From its first ever dividend in 2015, Medibank gave its investors an annual dividend pay raise every year until 2019. 2019 saw the company payout 15.6 cents per share in dividends, but this was reduced to 12 cents in 2020 largely thanks to the effects of the pandemic. 2021 saw the company begin to increase its shareholder payouts once again, which it has continued to do in 2022 so far.

So that's how we get to a 4.06% yield for Medibank shares today. Not too common for an ASX healthcare share at all.

At the current Medibank Private share price, this ASX 200 healthcare share has a market capitalisation of $8.81 billion. 

Motley Fool contributor Sebastian Bowen has positions in Telstra Corporation Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited and Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Healthcare Shares

Why is this ASX 300 healthcare stock up more than 17%?

Strong earnings have this company riding high.

Read more »

Two people comparing and analysing material.
Healthcare Shares

Could the CSL share price reach $200 in 2027?

It might sound ambitious after recent struggles, but the valuation required to get there is less demanding than you might…

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Mesoblast share price jumps on blockbuster news

It has been a good start to the week for this biotech company.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Australian Clinical Labs delivers profit growth and stronger margins in FY26

Australian Clinical Labs’ FY26 earnings reveal profit growth and margin improvements despite market headwinds.

Read more »

medical research laboratory assistant examines solutions in test tubes
Healthcare Shares

CSL shares are rallying. Could tomorrow's results pour fuel on the fire?

One strong month isn't enough. CSL needs earnings recovery to follow.

Read more »

A man with a perplexed expression on his face scratches his head.
Healthcare Shares

4DMedical shares are up 670% — but why have they halved?

Can the company turn its commercial momentum into another explosive share-price rebound?

Read more »

Businesswoman with a pleased smile reading on her laptop at a desk in the office with a look of satisfaction.
Healthcare Shares

Are CSL shares dirt cheap and a strong buy?

There is plenty for CSL to prove next week. The current valuation is why I am still interested.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

Why this ASX healthcare stock is a top rebound candidate with big upside 

This could be a perfect buy-low candidate.

Read more »